Life Sciences Times, Author at Life Sciences Times

Viridian Therapeutics’ Veligrotug Earns FDA Breakthrough Therapy Designation for Thyroid Eye Disease

May 8, 2025

Bain Capital, Botanic Properties Acquire Bedford Site for Biomanufacturing Redevelopment

May 7, 2025

MassBio Warns of Looming Crisis in U.S. Biotech Sector as Federal Cuts and Trade Barriers Mount

May 6, 2025

THIS WEEK'S STORIES

HAYA Therapeutics Secures $65 Million Series A to Advance RNA-Guided Therapies for Chronic and Age-Related Diseases

May 8, 2025

Everwell Health Acquires American River Nutrition in Third Strategic Deal in Three Months

May 5, 2025

eGenesis Appoints Dr. Jay Barth as Chief Medical Officer to Lead Clinical Strategy for Engineered Organ Programs

May 6, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Jaanuu Acquired by VentureOn Management in Strategic Asset Sale

Novellia Wins 2025 MedTech Breakthrough Award for AI Innovation in Health Record Integration

Between the Bridges Healing Center Launches Breakthrough Brain Stimulation Therapy for Mental Health

World Ovarian Cancer Coalition Launches Global Advisory Group to Confront World’s Deadliest Female Cancer

EDITOR PICKS